Views & Analysis | Perspectives on pharma industry issues

R&D

Clinical trials, various research areas, concept

Clinical Trials Round-Up – Jan to Feb 2026

Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.

R&D

pharmaphorum podcast Episode 248, Andrew McKinnon, Medable

AI in clinical development & ‘white space’, with Andrew McKi...

Andrew McKinnon, senior vice president and executive general manager at Medable, discussesleveraging AI to transform & accelerate clinical development

Digital

Sponsored

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

Digital

Accelerating the medical wheel with AI: From engagement to i...

Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.

R&D

Rare disease at an inflection point: Why the next wave will ...

As rare disease becomes more competitive, information parity is disappearing.

Digital

Tech & Trials: What’s all this about AI, then?

Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.

Digital

apps and telemedicine visual illustration

Driving growth with connected health

Connected health stands at the intersection of healthcare and technology, where innovation is reshaping patient care.

Digital

The fall and rise of digital therapeutics

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that

Sales & Marketing

virtual electronic medical record interface

Sponsored

5 forces reshaping pharma commercialisation in 2026

As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment

Sales & Marketing

Swiss train speeding across bridge against landscape background

A fast start to 2026 signals continued investor confidence i...

Key factors in Switzerland’s success that could make other European life sciences hubs more attractive to investors.

Digital

Sponsored

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

Digital

Accelerating the medical wheel with AI: From engagement to i...

Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.

Market Access

What rare disease commercialisation in Europe teaches us - a...

Rare disease launches are the ultimate stress test for European commercialisation.

Market Access

Biotech leaders: ‘They're shoving this industry into the arm...

At the Biotech Showcase during JPM Week, biotech leaders expressed frustration at the US's lack of concern about Chinese biotech progress.

Oncology

Sponsored

Collaboration & personalisation in rare disease R&D, with AO...

For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.

Oncology